HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sreenivasa Nattam Selected Research
Sreenivasa Nattam Research Topics
Disease
6
Neoplasms (Cancer)
10/2014 - 11/2005
4
Disease Progression
12/2018 - 12/2008
4
Leukemia
04/2014 - 11/2005
3
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2024 - 10/2009
3
Hypertension (High Blood Pressure)
01/2024 - 10/2014
3
Infections
10/2021 - 01/2009
3
Pancreatic Neoplasms (Pancreatic Cancer)
02/2012 - 11/2005
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2010 - 12/2008
2
Atrial Fibrillation
01/2024 - 10/2021
2
Lymphoma (Lymphomas)
01/2022 - 04/2014
2
Squamous Cell Carcinoma of Head and Neck
04/2012 - 03/2009
1
Ovarian Neoplasms (Ovarian Cancer)
10/2014
1
Fatigue
10/2014
1
Carcinoma (Carcinomatosis)
04/2011
1
Inflammation (Inflammations)
10/2009
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2009
1
Refractory Anemia
01/2009
1
Cytopenia
01/2009
1
Febrile Neutropenia
12/2008
1
Pneumonia (Pneumonitis)
12/2008
1
Adenocarcinoma
12/2008
Drug/Important Bio-Agent (IBA)
4
Gemcitabine
FDA Link
02/2012 - 11/2005
4
Bevacizumab (Avastin)
FDA Link
04/2011 - 11/2005
3
Rituximab (Mabthera)
FDA Link
04/2024 - 04/2014
3
ibrutinib
IBA
01/2024 - 12/2018
2
Bendamustine Hydrochloride
FDA Link
04/2024 - 12/2018
2
Cisplatin (Platino)
FDA Link
Generic
04/2011 - 12/2008
2
Pemetrexed (MTA)
FDA Link
11/2010 - 11/2009
2
Monoclonal Antibodies
IBA
10/2009 - 11/2005
1
Lenalidomide (CC 5013)
FDA Link
01/2022
1
temsirolimus
FDA Link
01/2022
1
olaparib
IBA
10/2014
1
cediranib (AZD2171)
IBA
10/2014
1
Platinum
IBA
10/2014
1
Filgrastim (Neupogen)
FDA Link
04/2014
1
Lapatinib (GW572016)
FDA Link
04/2012
1
Sorafenib (BAY 43-9006)
FDA Link
02/2012
1
Carboplatin (JM8)
FDA Link
Generic
11/2010
1
enzastaurin
IBA
11/2010
1
thiamine triphosphorate (TTP)
IBA
11/2009
1
Cetuximab (Erbitux)
FDA Link
11/2009
1
fludarabine
IBA
10/2009
1
Alemtuzumab (Campath)
FDA Link
10/2009
1
ErbB Receptors (EGF Receptor)
IBA
03/2009
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
03/2009
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2009
1
Topotecan (Hycamtin)
FDA Link
Generic
01/2009
1
Etoposide (VP 16)
FDA Link
Generic
12/2008
1
Docetaxel (Taxotere)
FDA Link
12/2008
1
Arsenic Trioxide (Trisenox)
FDA Link
12/2008
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2005
Therapy/Procedure
6
Therapeutics
01/2022 - 12/2008
2
Drug Therapy (Chemotherapy)
04/2014 - 11/2010
1
Erythrocyte Transfusion
01/2009
1
Chemoradiotherapy
12/2008